首页> 美国卫生研究院文献>Nucleic Acids Research >AptaBlocks: Designing RNA complexes and accelerating RNA-based drug delivery systems
【2h】

AptaBlocks: Designing RNA complexes and accelerating RNA-based drug delivery systems

机译:AptaBlocks:设计RNA复合物并加速基于RNA的药物递送系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

RNA-based therapeutics, i.e. the utilization of synthetic RNA molecules to alter cellular functions, have the potential to address targets which are currently out of scope for traditional drug design pipelines. This potential however hinges on the ability to selectively deliver and internalize therapeutic RNAs into cells of interest. Cell internalizing RNA aptamers selected against surface receptors and discriminatively expressed on target cells hold particular promise as suitable candidates for such delivery agents. Specifically, these aptamers can be combined with a therapeutic cargo and facilitate internalization of the cargo into the cell of interest. A recently proposed method to obtain such aptamer-cargo constructs employs a double-stranded “sticky bridge” where the complementary strands constituting the bridge are conjugated with the aptamer and the cargo respectively. The design of appropriate sticky bridge sequences however has proven highly challenging given the structural and functional constraints imposed on them during synthesis and administration. These include, but are not limited to, guaranteed formation and stability of the complex, non-interference with the aptamer or the cargo, as well as the prevention of spurious aggregation of the molecules during incubation. In order to address these issues, we have developed AptaBlocks - a computational method to design RNA complexes that hybridize via sticky bridges. The effectiveness of our approach has been verified computationally, and experimentally in the context of drug delivery to pancreatic cancer cells. Importantly, AptaBlocks is a general method for the assembly of nucleic acid systems that, in addition to designing of RNA-based drug delivery systems, can be used in other applications of RNA nanotechnology. AptaBlocks is available at .
机译:基于RNA的治疗方法,即利用合成的RNA分子改变细胞功能,有可能解决目前传统药物设计流程无法涵盖的目标。但是,这种潜力取决于选择性地将治疗性RNA传递和内化到目标细胞中的能力。针对表面受体选择并在靶细胞上有区别地表达的细胞内在化RNA适体具有作为此类递送剂的合适候选物的特殊前景。具体而言,这些适体可以与治疗性货物组合并促进货物内化到目的细胞中。获得这种适体-货物构建体的最近提出的方法采用双链“粘性桥”,其中构成桥的互补链分别与适体和货物缀合。然而,考虑到在合成和给药过程中施加于它们的结构和功能限制,适当的粘性桥序列的设计已被证明具有很高的挑战性。这些包括但不限于,确保复合物的形成和稳定性,不干扰适体或货物,以及防止在孵育过程中分子的虚假聚集。为了解决这些问题,我们开发了AptaBlocks-一种计算方法,可设计通过粘性桥杂交的RNA复合物。我们的方法的有效性已在药物和胰腺癌细胞中得到了计算和实验的验证。重要的是,AptaBlocks是组装核酸系统的通用方法,除了设计基于RNA的药物递送系统外,还可以用于RNA纳米技术的其他应用中。 AptaBlocks的网址为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号